What Aspire Scientific does

Aspire Scientific is an independent, UK-based medical communications agency founded in 2012 that provides B2B professional services to pharmaceutical and biotechnology companies. The firm partners with medical affairs, scientific communications, publications, clinical, and regulatory teams to translate complex clinical evidence into clear, credible communications across five core service lines: medical affairs, medical publications, scientific events, regulatory writing, and (newly formalised in 2026) AI and digital innovation. Client work spans 12+ therapy areas including oncology, cardiovascular and metabolic, immunology, neurology, and rare diseases, delivered by a 100% PhD-trained scientific team with a reported 95% five-year retention rate. The company operates from a registered office in Bolton, a new Manchester office opened in 2025, and an Oxfordshire office, with hybrid and remote working supported and a globally distributed client base.

The firm's technology layer centres on AI-enabled content development, intelligent literature discovery and evidence synthesis, and AI-embedded delivery workflows — all routed through bespoke AI governance frameworks with 100% human-in-the-loop review by scientific experts, overseen by a cross-functional innovation council. It also operates The Publication Plan, a freely accessible industry resource hub launched in 2015, and runs internal talent-development programmes including the Aspirations work-experience scheme and the Aspire Leadership Academy.

Revenue is generated through project-based and multi-year retainer engagements priced via custom scoping (no public pricing). Distribution is direct via a Business Development Lead and senior team relationships with no channel partners or resellers. The company is privately held by its four co-founders, including CEO Rick Flemming and Chief People & Business Officer Philippa Flemming, with no external investment or private-equity backing, and was independently certified as a Great Place to Work from 2022 onward.

Name

Aspire Scientific

Legal name

Aspire Scientific Ltd

Website

https://aspire-scientific.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Aspire Scientific is an independent UK-based medical communications agency serving pharma and biotech clients. Its 100% PhD-trained team delivers medical affairs, publications, scientific events, regulatory writing, and AI-augmented evidence communications across more than 12 therapy areas.

Ownership category

akta.pro rank

Product category

Medical Communications Services

NAICS

Other Scientific and Technical Consulting Services (54169), Management, Scientific, and Technical Consulting Services (5416)

akta.pro primary industry

Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF)

akta.pro secondary industries

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)

Keywords

• Medical communications
• Medical writing services
• Medical affairs consulting
• Pharmaceutical publications
• Regulatory writing services

Headquarters

HQ city

Bollington

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical communications professional services: B2B professional services delivered to pharma and biotech companies across medical affairs, medical publications, scientific events, regulatory writing, and AI & digital innovation. Services include strategy, content creation, training, and consulting. Revenue is generated through project-based and retainer engagements with evidence-focused teams.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Aspire Scientific provides evidence-led medical communications professional services to pharma and biotech clients. The offering spans five core service lines (Medical Affairs, Medical Publications, Scientific Events, Regulatory Writing, and AI and Digital Innovation), delivered by PhD-trained, CMPP-accredited scientific teams via project-based and retainer engagements.

Product overview

Aspire Scientific is an independent medical communications agency offering five interconnected core service lines: Medical Affairs, Medical Publications, Scientific Events, Regulatory Writing, and AI & Digital Innovation. These services work together to help pharma and biotech clients turn evidence into real-world impact by establishing the evidence base, shaping scientific stories, and enabling meaningful scientific exchange. The company also operates The Publication Plan as an informational resource hub, and runs talent development programmes including Aspirations (for aspiring medical writers) and the Aspire Leadership Academy (for emerging and established leaders).

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Affairs Services Strategic and scientific support for pharma and biotech medical affairs teams, including strategy development, tactical planning, scientific platforms/narratives/lexicons, stakeholder engagement, scientific content and educational materials, and scientific training and capability building.
• Medical Publications Services Insight-led strategic publication plans and high-impact publication outputs, including publication strategy and consultancy, publication planning, manuscripts, congress presentations, and narrative and systematic reviews.
• Scientific Events Services Strategic planning, content development, and insight synthesis for scientific congresses, symposia, and expert meetings, including congress support, symposia development, advisory boards, and post-event insight synthesis.
• Regulatory Writing Services High-quality clinical regulatory documentation for submissions to health authorities worldwide, including clinical study protocols and reports, investigator's brochures, Common Technical Document clinical overviews and summaries, patient narratives, and independent quality control services.
• AI and Digital Innovation Services AI-enabled content development and quality assurance, insight generation and evidence synthesis, AI-enabled delivery for consistency at scale, and bespoke AI governance frameworks with 100% human-in-the-loop expert oversight, guided by a digital-first, expert-led, structured approach.

Quantifiable outcome

• 95% five-year team retention rate
• +5 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

One partnership is on record.

• Medical Affairs Professional Society (MAPS)coreStrategic or Co-development PartnerAspire Scientific is an executive sponsor of MAPS Partner Circle Program. This partnership positions Aspire within the MAPS ecosystem and supports professional development and industry standards in medical affairs.

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Fishawack Health: Large PE-backed (Bridgepoint) medical communications and consulting group serving global pharma with a broad portfolio spanning medical affairs, publications, creative, and consulting. A scaled incumbent that competes for enterprise accounts Aspire may also target, with materially greater resources and geographic coverage.
• Caudex (IPG Health): Medical communications agency, now part of IPG Health's network, providing medical affairs, publications, and scientific services to pharma. Comparable on service offering but materially larger and backed by IPG's global healthcare communications infrastructure.
• Envision Pharma Group: Established medical communications and publications agency serving pharma with publication planning, medical affairs, and real-world evidence services. A larger, more established player that overlaps Aspire's publications and medical affairs offerings while operating at greater scale.

Others

• Springer Healthcare: Medical communications and publishing services arm of Springer Nature, serving pharma with publications, medical affairs, and educational content. Overlaps with Aspire on publications and medical affairs work, while leveraging Springer Nature's broader publishing and scientific publishing infrastructure.
• HEOR/Medical Communications Consultancies (e.g., Putnam Associates): Strategy and HEOR-focused consulting firms serving pharma that overlap with Aspire's medical affairs and evidence communications work on the strategic side. Included as an adjacent peer reflecting the broader ecosystem of evidence-to-impact services that pharma clients evaluate alongside medical communications specialists.

Direct peers

• Complete HealthVizion: Medical communications agency offering medical affairs, publications, and scientific services to pharma clients. Comparable to Aspire in scope and customer base, competing for similar mid-sized pharma accounts across therapy areas.
• AMICULUM: Independent UK-headquartered medical communications agency serving pharma and biotech across medical affairs, publications, and scientific exchange. Most structurally comparable to Aspire in terms of size, independence, and service mix, and competes for the same mid-sized pharma accounts.
• Nucleus Global: Medical communications agency network offering medical affairs, publications, and scientific services to global pharma clients. Comparable to Aspire on core offerings but with broader geographic reach and a network operating model that gives it scale advantages in enterprise accounts.
• Oxford PharmaGenesis: Independent UK-based medical communications agency focused on publications, medical affairs, and evidence-based communications for pharma clients. Directly comparable to Aspire on service offering, geographic base, and customer profile, though with a longer heritage and stronger publications heritage.
• CMC Connect: UK medical communications agency offering medical affairs, publications, and scientific services to pharma and biotech. Directly comparable to Aspire in scale, service mix, and customer segment, operating in the same competitive set for mid-sized pharma engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/aspire-scientific-ltd
• Instagraminstagram.com/aspire.scientific

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aspire Scientific